Curriculum vitae Thomas Felzmann - ACTIVARTIS Biotech GmbH

Bibliographie
1. Traxlmayr, M. W., D. Wesch, A. M. Dohnal, P. Funovics, M. B. Fischer, D. Kabelitz, and
T. Felzmann. 2010. Immune suppression by gammadelta T-cells as a potential regulatory
mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother 33:40-
52.
2. Simma, O., E. Zebedin, N. Neugebauer, C. Schellack, A. Pilz, S. Chang-Rodriguez, K. Lingnau,
E. Weisz, E. M. Putz, W. F. Pickl, T. Felzmann, M. Muller, T. Decker, V. Sexl, and D. Stoiber.
2009. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor
surveillance. Cancer Res 69:203-211.
3. Jurgens, B., U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger. 2009. Interferon-gammatriggered
indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic
cells induces regulatory activity in allogeneic T cells. Blood 114:3235-3243.
4. Dohnal, A. M., R. Luger, P. Paul, D. Fuchs, and T. Felzmann. 2009. CD40 ligation restores type 1
polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12
expression. J Cell Mol Med 13:1741-1750.
5. Dohnal, A. M., S. Graffi, V. Witt, C. Eichstill, D. Wagner, S. Ul-Haq, D. Wimmer, and
T. Felzmann. 2009. Comparative evaluation of techniques for the manufacturing of dendritic
cell-based cancer vaccines. J Cell Mol Med 13:125-135.
6. Dohnal, A. M., V. Witt, H. Hugel, W. Holter, H. Gadner, and T. Felzmann. 2007. Phase I study of
tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer.
Cytotherapy 9:755-770.
7. Wimpissinger, T. F., T. Felzmann, H. Hügel, P. Funovics, and W. Stackl. 2006. Treatment of
advanced renal cell carcinoma with tumor lysate pulsed IL-12 secreting autologous dendritic
cells. J Clin Oncol 24:14585.
8. Dohnal, A. M., A. Inthal, T. Felzmann, S. Glatt, W. Sommergruber, G. Mann, H. Gadner, and
E. R. Panzer-Grumayer. 2006. Leukemia-associated antigenic isoforms induce a specific
immune response in children with T-ALL. Int J Cancer 119:2870-2877.
9. Hüttner, K. G., S. K. Breuer, P. Paul, O. Majdic, A. Heitger, and T. Felzmann. 2005. Generation
of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer
Immunol Immunother 54:67-77.
10. Felzmann, T., K. G. Huttner, S. K. Breuer, D. Wimmer, G. Ressmann, D. Wagner, P. Paul,
M. Lehner, A. Heitger, and W. Holter. 2005. Semi-mature IL-12 secreting dendritic cells
present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol
Immunother 54:769-780.
11. Lehner, M., J. Stockl, O. Majdic, W. Knapp, K. Huttner, T. Felzmann, and W. Holter. 2003. MHC
class II antigen signaling induces homotypic and heterotypic cluster formation of human
mature monocyte derived dendritic cells in the absence of cell death. Hum Immunol 64:762-
770.
12. Felzmann, T., V. Witt, D. Wimmer, G. Ressmann, D. Wagner, P. Paul, K. Huttner, and
G. Fritsch. 2003. Monocyte enrichment from leukapharesis products for the generation of
DCs by plastic adherence, or by positive or negative selection. Cytotherapy 5:391-398.
13. Felzmann, T., H. Gadner, and W. Holter. 2002. Dendritic cells as adjuvants in antitumor
immune therapy. Onkologie 25:456-464.
14. Felzmann, T. 2002. Use of dendritic cells (DCs) expressing interleukin 12 (IL-12). Austria.
15. Lehner, M., T. Felzmann, K. Clodi, and W. Holter. 2001. Type I interferons in combination with
bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 98:736-742.
16. Lehner, M., T. Felzmann, K. Clodi, and K. Holter. 2001. Type I interferons in combination with
bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 98:736-742.